Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Oja

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Scandinavian Journal of Clinical and Laboratory Investigation|July 16, 2008
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 studyP Niinisalo, A Raitala, M Pertovaara, et al.
British Journal of Pharmacology|September 29, 2011
Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxationA Lehmann, M Antonsson, A Aurell-Holmberg, et al.
Journal of Medical Virology|February 18, 2011
High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemicaTuula K Outinen, Satu M Mäkelä, Ilpo O Ala-Houhala, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2009
(R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of actionAnders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Scandinavian Journal of Clinical and Laboratory Investigation|July 16, 2008
Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 studyP Niinisalo, A Raitala, M Pertovaara, et al.
British Journal of Pharmacology|September 29, 2011
Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxationA Lehmann, M Antonsson, A Aurell-Holmberg, et al.
Journal of Medical Virology|February 18, 2011
High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemicaTuula K Outinen, Satu M Mäkelä, Ilpo O Ala-Houhala, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2009
(R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of actionAnders Lehmann, Madeleine Antonsson, Ann Aurell Holmberg, et al.
Pageof 25